Literature DB >> 22379064

Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia.

Suzan P van Mens1, Sabine C A Meijvis, Jan C Grutters, Bart J M Vlaminckx, Willem J W Bos, Ger T Rijkers.   

Abstract

In this study, the effect of dexamethasone on the formation of pneumococcal antibodies during community-acquired pneumonia (CAP) was investigated. No differences between CAP patients receiving dexamethasone as additional therapy and patients receiving a placebo were found with respect to immune response rates and mean baseline and convalescent-phase antibody concentrations.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22379064      PMCID： PMC3346342          DOI： 10.1128/CVI.05697-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  16 in total

1.  Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.

Authors:  M Väkeväinen; C Eklund; J Eskola; H Käyhty
Journal:  J Infect Dis       Date:  2001-08-14       Impact factor: 5.226

Review 2.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.

Authors:  Turk Rhen; John A Cidlowski
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

3.  Anti-pneumococcal antibody response in normal subjects: a meta-analysis.

Authors:  E S Go; Z K Ballas
Journal:  J Allergy Clin Immunol       Date:  1996-07       Impact factor: 10.793

4.  Effects of long-term low-dose corticosteroid therapy on humoral immunity.

Authors:  Mary E Fedor; Arye Rubinstein
Journal:  Ann Allergy Asthma Immunol       Date:  2006-07       Impact factor: 6.347

5.  Effects of glucocorticoids on humoral and cellular immunity and on airway inflammation in patients with steroid-dependent intractable asthma.

Authors:  Y Tanizaki; H Kitani; T Mifune; F Mitsunobu; K Kajimoto; K Sugimoto
Journal:  J Asthma       Date:  1993       Impact factor: 2.515

6.  Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids.

Authors:  A de Roux; N Schmidt; M Rose; S Zielen; M Pletz; H Lode
Journal:  Respir Med       Date:  2004-12       Impact factor: 3.415

7.  In vitro and in vivo effect of glucocorticoids on IgE and IgG subclass secretion.

Authors:  F H Klebl; G Weber; J R Kalden; H G Nüsslein
Journal:  Clin Exp Allergy       Date:  1994-11       Impact factor: 5.018

8.  Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone.

Authors:  W T Butler; R D Rossen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

9.  Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination.

Authors:  D M Musher; J E Groover; J M Rowland; D A Watson; J B Struewing; R E Baughn; M A Mufson
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

10.  IgG subclass deficiency associated with corticosteroids in obstructive lung disease.

Authors:  W B Klaustermeyer; M E Gianos; M L Kurohara; H T Dao; D C Heiner
Journal:  Chest       Date:  1992-10       Impact factor: 9.410
View more
  3 in total

1.  Based on Unmodified Aptamer-Gold Nanoparticles Colorimetric Detection of Dexamethasone in Food.

Authors:  Yadi Qin; Hayilati Bubiajiaer; Jun Yao; Minwei Zhang
Journal:  Biosensors (Basel)       Date:  2022-04-14

2.  A Case of Long-Term Seronegative Human Immunodeficiency Virus (HIV) Infection: The Importance of the Humoral Response to HIV.

Authors:  Reed A C Siemieniuk; Frank van der Meer; Guido van Marle; M John Gill
Journal:  Open Forum Infect Dis       Date:  2015-12-23       Impact factor: 3.835

3.  Selection of high affinity aptamer-ligand for dexamethasone and its electrochemical biosensor.

Authors:  Somia Mehennaoui; Sujittra Poorahong; Gaston Contreras Jimenez; Mohamed Siaj
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.